Nigel P.C. Walker

机构：Arcus Biosciences (United States) · ORCID：0009-0002-5838-8311

发表论文 216 篇 · 总被引 12842 次 · h-index 40

代表论文

• Discovery of Casdatifan, Part I: Design and Characterization of Tetrahydroquinoline Inhibitors of Hypoxia-Inducible Factor-2α (2026 · Journal of Medicinal Chemistry · 被引 2)
• Harnessing CD39 inhibition to boost antitumor immunity with extracellular ATP (2025 · The Journal of Immunology · 被引 2)
• 507 TIGIT blockade by monoclonal antibodies promotes T cell activation and anti-tumor activity that is not dependent on a functionalized Fc domain (2024 · Regular and Young Investigator Award Abstracts · 被引 1)
• Figure S7 from Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid Tumors (2026)
• Figure S1 from Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid Tumors (2026)
• Figure S3 from Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid Tumors (2026)